Q3 2012

Filed Nov 19, 2012 · 10-Q · 50 days after period end · 0001193125-12-475491

Q3 2012 · 10-Q

Revenue—

Net Income

$640.29K

no prior Q3 2011 on file

EPS Diluted

$0.05

no prior Q3 2011 on file

Operating Income-$137,469—

Same quarter

no prior Q3 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2012 · filed Nov 19, 2012 · 50 d after period end

Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR